Yumi Murakami
Memorial Hospital of South Bend
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yumi Murakami.
European Journal of Pediatrics | 2007
Takao Yoshihara; Toshihiko Imamura; Kentaro Yokoi; Mayumi Shibata; Gen Kano; Shinya Osone; Kanae Yagi; Shinjiro Todo; Yumi Murakami; Yuichi Yamada; Hiroyuki Yamada; Shinji Satomura; Hiroyuki Ishida
PFAPA syndrome is a clinical entity of unknown etiology characterized by periodic episodes of high fever accompanied by aphthous stomatitis, pharyngitis/tonsillitis, and cervical adenitis [3, 5]. Since specific laboratory abnormalities for the PFAPA syndrome are inexistent, it is usually diagnosed clinically after excluding other probable causes of the fever, such as infection [1]. In PFAPA patients, discriminating between a fever attack due to bacterial infection and a fever attack due to noninfectious inflammation constitutes a major difficulty. Because procalcitonin, a propeptide of calcitonin, is reported to be a sensitive marker of systemic bacterial infection [2, 4], we followed peripheral leukocyte counts, CRP values and procalcitonin concentrations during the fever attacks associated with PFAPA syndrome in the hope of defining reliable criteria for its diagnosis. We determined serum procalcitonin concentrations in six PFAPA syndrome patients (two males and four females) with a median age of 7.5 (range 3–10) years and in 32 controls (bacterial, n=10 and non-bacterial, n=22). Sampling was performed on the third to fifth day of fever. In the PFAPA syndrome patients, febrile episodes started at the median age of 2.5 (range 1–7) years with each episode lasting 5–7 days and recurring every 3–4 weeks. The ethical committees of our institutes approved the study protocol and the guardians of all the patients gave their informed consent. Serum procalcitonin concentrations were measured by using the fully automated enzyme immunoluminescent assay (Wako Pure Chemical Industries, Ltd.), which employs katacalcin monoclonal antibody and calcitonin polyclonal antibody labeled with peroxidase for SphereLight 180 (Olympus Corporation). The detection limit was 0.1 ng/ml and the normal reference was set at <0.5 ng/ml. In PFAPA patients, the correlations between procalcitonin, CRP values and leukocyte counts were examined over 13 febrile episodes. Serum procalcitonin values ranged from 0.20 to 11.36 (median value 1.05) ng/ml in positive control subjects (Table 1), while all the negative controls had undetectable levels. During febrile episodes in PFAPA patients, which were confirmed not to be due to adenoviral or group A streptococcal infections, leukocyte counts and serum concentrations of CRP were invariably and significantly Eur J Pediatr (2007) 166:621–622 DOI 10.1007/s00431-006-0281-2
Archive | 1995
Gen Suzuki; Shohei Sugawara; Hiroya Tanigawa; Machio Moriuchi; Yoshio Nagashima; Yasuhiro Nakajima; Hiroyuki Arita; Yumi Murakami
Archive | 1995
Gen Suzuki; Shohei Sugawara; Hiroya Tanigawa; Machio Moriuchi; Yoshio Nagashima; Yasuhiro Nakajima; Hiroyuki Arita; Yumi Murakami
Archive | 2000
Masaru Ando; Toru Ishihara; Masao Masugi; Yumi Murakami; Yoshio Nagashima; Hitoshi Sato; Kotaro Shinkawa; 仁 佐藤; 大 安藤; 晃太郎 新川; 由美 村上; 美雄 永嶋; 徹 石原; 正男 馬杉
Archive | 2000
Masaru Ando; Toru Ishihara; Masao Masugi; Yumi Murakami; Yoshio Nagashima; Hitoshi Sato; Kotaro Shinkawa; 仁 佐藤; 大 安藤; 晃太郎 新川; 由美 村上; 美雄 永嶋; 徹 石原; 正男 馬杉
Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2010
Keiji Yoshioka; Yumi Murakami; Kyoko Ego; Yasuhiro Nakajima
Archive | 2004
Harumi Kawashima; Yumi Murakami; Masakatsu Okubo; Tsutomu Sasaki; 努 佐々木; 雅且 大久保; 晴美 川島; 由美 村上
Archive | 1995
Gen Suzuki; Shohei Sugawara; Hiroya Tanigawa; Machio Moriuchi; Yoshio Nagashima; Yasuhiro Nakajima; Hiroyuki Arita; Yumi Murakami
Archive | 2008
Harumi Kawashima; Yumi Murakami; Hidenori Okuda; 英範 奥田; 晴美 川島; 由美 村上
Journal of medical technology | 2008
Yasuhito Nakajima; Kyoko Ego; Yumi Murakami; Keiji Yoshioka